CAA Use Tied to Higher Arthroplasty Risk - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

CAA Use Tied to Higher Arthroplasty Risk

In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

  • By

  • Andrea Surnit

  • June 1, 2026

  • 6 min

Share

  • 1

    Centrally acting analgesics are linked to an 81% higher hazard of knee or hip replacement compared to selective serotonin reuptake inhibitors.

  • 2

    The study involved 11,734 patients initiating centrally acting analgesics and 11,734 initiating SSRIs, with a median follow-up of 9.5 years.

  • 3

    Deaths occurred more frequently among SSRI initiators (11.0%) than centrally acting analgesic initiators (7.1%) in the matched cohort.

  • 4

    Tricyclic antidepressants and gabapentinoids also showed increased hazards for knee or hip replacement compared to SSRIs.

  • 5

    The researchers cautioned that the study could not establish causality and residual confounding by indication may exist.

Original Source(s)

CAA Use Tied to Higher Arthroplasty Risk

  • by Andrea Surnit

  • June 1, 2026

Related Content

Spondyloarthritis function varies by sex

Women had greater functional deterioration over 17 years, while permanent work disability did not differ significantly between sexes.

How does IBD relate to joint infection risk?

Investigators assessed 90-day outcomes among patients with IBD who underwent elective total joint arthroplasty.

Clinical outcomes of internal iliosciatic fixation using a conventional reconstruction plate via an anterior approach for acetabular fractures involving the posterior column